Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Sophiris Bio reports results from phase III trial of PRX-302 in BPH

Nov. 13, 2015

Antagonism of CCR2/5 in type 2 diabetic nephropathy

Nov. 9, 2015

SUL-121, a novel candidate to treat diabetic nephropathy

Nov. 9, 2015

Preclinical toxicity study results for Pyridorin will support planned IND filing

Nov. 9, 2015

Quark Pharmaceuticals plans new trials of QPI-1002

Nov. 3, 2015

Isis Pharmaceuticals begins phase II study of ISIS-FXIRx in end-stage renal disease

Nov. 3, 2015

Taiho starts phase I trial of TAS-303 in women with stress urinary incontinence

Nov. 3, 2015

Revive Therapeutics' bucillamine receives orphan drug designation for cystinuria

Oct. 30, 2015

Researchers devise mouse model of nocturnal polyuria

Oct. 26, 2015

AF-219 improves symptoms in patients with interstitial cystitis/bladder pain syndrome

Oct. 26, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...